Trade name: ActHIB, PedvaxHIB, Hiberix
Generic names: Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) Solution for Intramuscular Injection, Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate),
Indication and Usage:
- ActHIB is a vaccine indicated for the prevention of invasive disease caused by Haemophilus influenzae type b. ActHIB vaccine is approved for use as a four dose series in infants and children 2 months through 5 years of age
- Liquid PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age. Liquid PedvaxHIB will not protect against disease caused by Haemophilus influenzae other than type b or against other microorganisms that cause invasive disease such as meningitis or sepsis. As with any vaccine, vaccination with Liquid PedvaxHIB may not result in a protective antibody response in all individuals given the vaccine.
- HIBERIX is a vaccine indicated for active immunization for the prevention of invasive disease caused by Haemophilus influenzae type b. HIBERIX is approved for use in children aged 6 weeks through 4 years (prior to fifth birthday).
Manufacturer-listed adverse reactions: HIB vaccine can cause…
ActHIB can cause: Anaphylaxis, Urticaria (Hives), Angioedema (facial swelling), Convulsions, Extensive limb swelling, Peripheral edema, Pruritus (itchy skin), Rash.
PedvaxHIB can cause: Early onset Hib disease, Guillain-Barré syndrome, Lymphadenopathy, Febrile seizures, Sterile injection site abscess.
Hiberix can cause: Extensive swelling, Injection site induration, Anaphylactic/Anaphylactoid reactions, Angioedema, Convulsions, Hypotonic-Hyporesponsive Episode, Somnolence (sleepiness), Syncope, Vasovagal responses to injection (fainting), Apnea, Rash/Uticaria (Hives).
Need more info? Click the link below for a helpful infographic you can view + save on your device.
